citrulline has been researched along with EBV Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| 'tHart, BA; Gran, B; Kap, YS; Laman, JD; Morandi, E | 1 |
| Anzilotti, C; Chimenti, D; Migliorini, P; Pratesi, F; Tommasi, C | 1 |
1 review(s) available for citrulline and EBV Infections
| Article | Year |
|---|---|
EBV Infection and Multiple Sclerosis: Lessons from a Marmoset Model.
Topics: Animals; Antigen Presentation; B-Lymphocytes; Citrulline; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunity, Cellular; Major Histocompatibility Complex; Multiple Sclerosis; T-Lymphocytes | 2016 |
1 other study(ies) available for citrulline and EBV Infections
| Article | Year |
|---|---|
Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Antibodies, Viral; Arthritis, Rheumatoid; Chromatography, Affinity; Citrulline; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Female; Filaggrin Proteins; Humans; Male; Middle Aged; Nucleoproteins | 2006 |